Literature DB >> 21402566

Increased running speed and pre-race muscle damage as risk factors for exercise-associated muscle cramps in a 56 km ultra-marathon: a prospective cohort study.

Martin P Schwellnus1, Siddieq Allie, Wayne Derman, Malcolm Collins.   

Abstract

BACKGROUND: Despite the high prevalence of exercise-associated muscle cramping (EAMC) in endurance runners, the aetiology and risk factors for this condition are not fully understood.
PURPOSE: The purpose of this prospective cohort study was to identify risk factors associated with the development of EAMC in ultra-distance runners.
METHODS: 49 runners participating in a 56 km race completed a validated pre-race questionnaire. Pre-race muscle pain in the calves, hamstrings and quadriceps muscles was recorded (visual analogue scale) and pre-race serum creatine kinase (CK) activity was measured. 20 runners reported EAMC (EAMC group) during or within 6 h after the event, while 29 runners reported no cramping (CON group).
RESULTS: EAMC was not associated with age, body mass index, sex, recent and past personal best running times, pre-race muscle pain and pre-race training (duration and frequency). Runners in the EAMC group tended to report on average longer training sessions during the 3 days before the race (EAMC 1.2 (1.1), CON 0.6 (1.0); p=0.077). Significant risk factors for EAMC were a past history of EAMC (EAMC 100%, CON 48%; p<0.001) and a faster running time (min) for the first 28 km split time of the race (EAMC 144 (20), CON 157 (14); p=0.029) despite being matched for recent (<15 weeks before race) personal best times in the 42.2 km race. Pre-race CK activity tended to be higher in the EAMC group (EAMC 89 (80), CON 58 (35); p=0.066).
CONCLUSIONS: Novel risk factors for EAMC in distance runners are a past history of EAMC, faster running pace at the early stage of a race and possibly pre-race muscle damage.

Entities:  

Mesh:

Year:  2011        PMID: 21402566     DOI: 10.1136/bjsm.2010.082677

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  8 in total

1.  National Athletic Trainers' Association Position Statement: Exertional Heat Illnesses.

Authors:  Douglas J Casa; Julie K DeMartini; Michael F Bergeron; Dave Csillan; E Randy Eichner; Rebecca M Lopez; Michael S Ferrara; Kevin C Miller; Francis O'Connor; Michael N Sawka; Susan W Yeargin
Journal:  J Athl Train       Date:  2015-09       Impact factor: 2.860

Review 2.  Exercise-Associated Muscle Cramps in the Tennis Player.

Authors:  Wesley Troyer; Ally Render; Neeru Jayanthi
Journal:  Curr Rev Musculoskelet Med       Date:  2020-10

3.  [Effectiveness of Saccharomyces boulardii combined with phototherapy in the treatment of hyperbilirubinemia in neonates: a prospective randomized controlled trial].

Authors:  Wei Tang; Hong-Yan Lu; Qin Sun; Wei-Min Xu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-11

4.  Effect of oral rehydration solution versus spring water intake during exercise in the heat on muscle cramp susceptibility of young men.

Authors:  Wing Yin Lau; Haruyasu Kato; Kazunori Nosaka
Journal:  J Int Soc Sports Nutr       Date:  2021-03-15       Impact factor: 5.150

5.  An Evidence-Based Review of the Pathophysiology, Treatment, and Prevention of Exercise Associated Muscle Cramps.

Authors:  Kevin C Miller; Brendon P McDermott; Susan W Yeargin; Aidan Fiol; Martin P Schwellnus
Journal:  J Athl Train       Date:  2021-06-29       Impact factor: 2.860

6.  Muscle Cramping During a 161-km Ultramarathon: Comparison of Characteristics of Those With and Without Cramping.

Authors:  Martin D Hoffman; Kristin J Stuempfle
Journal:  Sports Med Open       Date:  2015-05-21

7.  What are the Limiting Factors During an Ultra-Marathon? A Systematic Review of the Scientific Literature.

Authors:  Arkaitz Garbisu-Hualde; Jordan Santos-Concejero
Journal:  J Hum Kinet       Date:  2020-03-31       Impact factor: 2.193

Review 8.  Effects of Sodium Intake on Health and Performance in Endurance and Ultra-Endurance Sports.

Authors:  Eleftherios Veniamakis; Georgios Kaplanis; Panagiotis Voulgaris; Pantelis T Nikolaidis
Journal:  Int J Environ Res Public Health       Date:  2022-03-19       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.